AVVASEPT Vaginal Douche is a broad-spectrum topical antiseptic solution for intimate hygiene, powered by Miramistin monohydrate. It provides comprehensive protection against bacterial, viral, and fungal infections, making it the preferred antiseptic choice for gynaecological and intimate care applications
Active Ingredient
Active Substance: Miramistin monohydrate (0.01%) — a cationic antiseptic agent with a unique amphiphilic structure that integrates into microbial cell membranes, causing irreversible damage.
Key pharmacological properties:
✓ Broad-spectrum antimicrobial activity (gram-positive and gram-negative bacteria)
✓ Effective against a wide range of viruses and fungi
✓ No systemic toxicity — safe for mucous membranes
✓ Non-irritant; well-tolerated with repeated use
✓ Does not disrupt normal vaginal microflora at therapeutic concentrations
Clinical Indications & Therapeutic Uses
AVVASEPT Vaginal Douche is indicated for:
✓ Prevention and management of vaginitis
✓ Sexually transmitted disease (STD) prevention
✓ Postpartum care and hygiene
✓ Pre- and postoperative disinfection in gynaecological procedures
Proven antiseptic activity against the following pathogens:
• Candida species (Candidiasis)
• Trichomonas vaginalis (Trichomoniasis)
• Neisseria gonorrhoeae (Gonorrhoea)
• Chlamydia trachomatis (Chlamydia)
• Herpes simplex virus (HSV)
• Human papillomavirus (HPV)
• Staphylococcus aureus, Streptococcus spp., and other common pathogens
Safety Profile
AVVASEPT demonstrates an excellent safety profile, supported by clinical evidence:
✓ Non-irritant formulation safe for sensitive mucous membranes
✓ No systemic absorption — localised action only
✓ No reported development of clinically significant microbial resistance
✓ Compatible with vaginal tissue — does not alter normal flora at recommended dosage
✓ Suitable for use across different patient groups including postpartum patients
